CRBP
CRBP
NASDAQ · Biotechnology

Corbus Pharmaceuticals Holdi

Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.83
+0.44 (+5.95%)
As of Feb 8, 2:09 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +55.2% upside
Low Target $8.71
Average Target $12.15
High Target $17.60
Current Price $7.83
Current
$7.83
Target
$12.15
$8.71 $12.15 avg $17.60
Scenario Analysis
Bear Case
$8.71
11.2%
Low target
Base Case
$12.15
+55.2%
Avg target
Bull Case
$17.60
+124.8%
High target
Risk/Reward
11.1x
Highly favorable
Price in Context
52-Week High
$14.86
-47.3% from high
52-Week Low
$7.95
+-1.5% from low
Target vs 52W High
$12.15
-18.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%